findmyKOL

Brian Khong, DO

Basic profile

Endocrinology, Diabetes & Metabolism

ORCIDNPI
RegionSanta Rosa, CA · WestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Brian Khong is an Endocrinology/Metabolic physician. OpenAlex indexes 31 publications with 486 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
31publications

Distinct works indexed by OpenAlex, matched via ORCID.

486citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3883 Airway Dr
Santa Rosa, CA 954031670

Telephone

707-521-7735

Provider last certified this registry record 15 Nov 2024.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    78.7%
    RANK Ligand Inhibitor78.4%
    Denosumab100%Prolia0%
    Part D + Part B<11 patients
    Bisphosphonates0.2%
    Risedronate Sodium100%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    11.1%
    GLP-1 receptor agonist5%
    Ozempic52%Trulicity25%Mounjaro19%Wegovy4%
    Part D<11 patients
    Insulin Analog2.9%
    Lantus Solostar36%Humalog Kwikpen U-10014%Humalog Kwikpen U-2009%Tresiba Flextouch U-1009%Humalog8%Novolog Flexpen8%Fiasp Flextouch8%Insulin Lispro8%
    Part D<11 patients

    + 4 more classes in this area

  • Hormonal (systemic)

    6.8%
    l-Thyroxine4.6%
    Levothyroxine Sodium84%Synthroid16%
    Part D87 patients
    Thyroid Hormone Synthesis Inhibitor1.2%
    Methimazole100%
    Part D29 patients

    + 3 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”